[Graft schizophrenia].
Shirakawa
Osamu
O
Division of Psychiatry and Neurology, Faculty of Medical Sciences, Kobe University Graduate School of Medicine.
Yanagi
Masaya
M
Hattori
Haruki
H
D014151:Anti-Anxiety Agents / Q000627:therapeutic use; D014150:Antipsychotic Agents / Q000008:administration & dosage / Q000009:adverse effects; D004359:Drug Therapy, Combination; D006801:Humans; D008607:Intellectual Disability / Q000150:complications*; D012559:Schizophrenia / Q000453:epidemiology / Q000209:etiology* / Q000628:therapy; D012565:Schizophrenic Psychology
D014151:Anti-Anxiety Agents; D014150:Antipsychotic Agents